No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
AtriCure to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Pain Management Devices Global Analysis Report 2024-2034 Featuring Abbott Laboratories, Boston Scientific, Medtronic, Nevro, Baxter, OMRON, Stryker, Teleflex, ICU Medical, AtriCure, and Zynex
AtriCure Coverage Assumed by JP Morgan at Overweight
J.P. Morgan Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $40
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC) and Mettler-Toledo (MTD)
Cracking The Code: Understanding Analyst Reviews For AtriCure